NVR vs TXMD · P/E 15, rev $10.52B vs rev $1.8M
NVR Inc (NVR) versus TherapeuticsMD Inc (TXMD) — a side-by-side from cached financials, not a winner call.
NVR Inc (NVR) is a residential construction company listed on NYSE.
TherapeuticsMD Inc (TXMD) is a drug manufacturers - specialty & generic company listed on US.
Latest reported NVR revenue for 2024-12-31 was $10.52B. Net income was $1.68B. Revenue was up 10.6% from 2023-12-31 to 2024-12-31. NVR currently screens at market cap $16.94B and trailing P/E 15.3.
Latest reported TXMD revenue for 2024-12-31 was $1.8M. Net income was -$2.2M. Revenue was up 35.3% from 2023-12-31 to 2024-12-31. TXMD currently screens at market cap $13.7M.
NVR currently screens at market cap $16.94B and trailing P/E 15.3. TXMD currently screens at market cap $13.7M.
Not investment advice. Open the NVR and TXMD stock pages for the full models.
Not investment advice.